News and Trends 31 Mar 2023
Destiny Pharma gel reduces nasal staph in surgery patients
Destiny Pharma has revealed data showing its drug reduced Staphylococcus aureus in the nasal passage of pre-op cardiac surgery patients.…
Cardiovascular disease
- Latest Posts
News and Trends 10 Feb 2023
Heartseed and Novo Nordisk dose first patient in heart failure cell therapy study
Heartseed Inc. and Novo Nordisk A/S say Heartseed has successfully dosed the first patient in a phase 1/2 clinical study…
News and Trends 2 Feb 2023
Possible drug targets from Korean atherosclerosis research
Research suggests that the enzyme phosphoenolpyruvate carboxykinase 2 (PCK2) and its gene play a role in the development of vascular…
News and Trends 24 Jan 2023
Ubiquigent and University of Glasgow to collaborate on drug discovery
Ubiquigent Limited, a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high…
ADVERTISEMENT
In Depth 10 Jan 2023
Innovative biomaterials are revolutionizing tissue regeneration
Scientists are increasingly realizing the potential of biomaterials to help with many tasks. A key area biomaterials are being used…
News and Trends 15 Dec 2022
Cell reprogramming can reverse fibrosis after heart attack
Researchers in Japan may have found a way to repair cardiac damage in patients suffering from chronic heart attack and…
News and Trends 5 Dec 2022
Fallouh Healthcare’s device to give early diagnosis for post-surgery strangulation risk
U.K.-based Fallouh Healthcare is developing a device to monitor cardiac patients after surgery, which is when a condition, called cardiac…
News and Trends 23 Nov 2022
Trial to start for new heart attack drug
A potential new drug to improve the long-term outcomes for heart attack patients will be trialed in the U.K. With…
Interview 18 Nov 2022
How cardioids can usher in the next generation of drug discovery
The California-based Molecular Devices brings automated 3D cell culture and image analysis together with HeartBeat.bio’s cardioid technology to enable unique…
More News! 15 Nov 2022
Sequana Medical has positive results for heart failure therapy drug
Sequana Medical has had some very positive top-line results from a phase 2a study, that the company says reinforces its…
News and Trends 7 Nov 2022
Proteins identified by FunSel and developed by Forcefield can preserve heart function
Forcefield Therapeutics, has presented positive preclinical data on three proteins identified by it FunSel platform that have the potential to…
In Depth 11 Oct 2022
The biggest private biotech investments in September 2022
The companies Acelyrin, InnovaFeed and Arsenal Biosciences bagged the biggest biotech investments in September 2022, with insect protein and cell…
News and Trends 6 Oct 2022
Novartis Biome UK Heart Health Catalyst 2022 winners announced
Novartis Pharmaceuticals UK has announced that Xim, creators of Lifelight, and PocDoc are the successful companies of the Novartis Biome…
News and Trends 22 Sep 2022
Rivus Pharmaceuticals raises $132M for treatment of obesity and cardio-metabolic disorders
Rivus Pharmaceuticals Inc. has completed a $132 million series B financing round. It was led by RA Capital Management with…
News and Trends 12 Sep 2022
Cuffless device worn 24/7 can lower blood pressure, says Aktiia
A company making cuffless monitors for blood pressure says a significant and sustained reduction has been achieved for patients wearing…
News and Trends 1 Sep 2022
Brainomix awarded tender to deploy AI stroke imaging across whole of Hungary
Artificial intelligence (AI) stroke imaging will be deployed across centers in Hungary after Brainomix was awarded a national tender. The…
ADVERTISEMENT
News and Trends 22 Aug 2022
Vaderis emerges from stealth to start HTT trial
Vaderis Therapeutics AG, a clinical stage biotech company focused on developing treatments for rare diseases associated with vascular malformations, has…
News and Trends 13 Jul 2022
Sanofi sells two portfolios of established products to Neuraxpharma
Two drugs portfolios with products to treat the central nervous system, pain and vascular disease have been bought by pharmaceutical…
News and Trends 5 Jul 2022
Novartis Pharmaceuticals UK launches health-tech investor partnership for cardiovascular care
Novartis Pharmaceuticals UK has launched the Novartis Biome UK Heart Health Catalyst 2022, in a world-first investor partnership with Medtronic…
News and Trends 30 Jun 2022
Acticor Biotech gets patent for cardiovascular emergency treatment product
French company Acticor Biotech has announced the European Patent Office (EPO) has granted a new patent that provides protection for…
